US EditionHeartflow’s FFRCT Added to CCTA for CAD Diagnostic Pathway Evaluated in FISH&CHIPS Study - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Heartflow’s FFRCT Added to CCTA for CAD Diagnostic Pathway Evaluated in FISH&CHIPS Study - Cardiac Interventions Today
May 12, 2025—Heartflow, Inc., a developer of artificial intelligence (AI) technology for coronary artery disease (CAD), recently announced 2-year data from the real-world, multicenter, retrospective FISH&CHIPS study in the United Kingdom. The study was conducted by the National Health Service (NHS) England. It was designed to assess the incremental impact of adding Heartflow fractional flow reserve (FFRCT) derived from coronary CT angiography (C…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
